Since NHS-muIL12 targets the necrotic areas of tumors, the enhanced PD-L1 expression level is probably associated with NK and CD8+ T cells in the tumor microenvironment and their propensity for local IFN-γ production. This evidence concerns the gene CD8A and neoplasm.